drugset / Trial / NCT06846866
A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of BMS-986419 (Part 1) and the effects of multiple doses of BMS-986419 on cardiac repolarization (Part 2) in healthy participants.
Timeline
- Start
- 2025-02-27
- Primary completion
- 2025-10-21
- Completion
- 2025-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986419 | Unknown | — | — |
| Subject | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.